To ask the Secretary of State for Health and Social Care, if he will take steps to support the implementation of Artificial Intelligence in the diagnosis of bowel cancer; and whether he has made an assessment of the barriers to effective adoption of that implementation.
Answered on
14 November 2024
We recognise the importance of innovation and artificial intelligence (AI) in improving cancer diagnosis. We are supportive of the use of AI to support the diagnosis of many types of cancer, including bowel cancer. New AI technologies are being developed with the potential to accelerate the diagnosis and treatment for diseases such as cancer. The NHS AI Lab has provided £113 million, through the NHS AI Health and Care Awards, to 86 AI technologies, which are live in 40% of National Health Service acute trusts in England, and hundreds of Primary Care Networks across the United Kingdom. Many of these AI technologies are being tested to support with cancer diagnosis.
The Department is carrying out work to assess the barriers to effective adoption and improve the way AI tools are deployed across the NHS through a number of initiatives. The NHS AI Lab’s Ethics Initiative invests in research and practical interventions that could strengthen the ethical adoption of AI within health and care, and addresses risks and concerns over their use. Additionally, the NHS AI and Digital regulations service, in partnership with healthcare regulators, gives innovators and health and care providers a one-stop-shop for support, information, and guidance on the regulation and evaluation of AI technologies.